As genetic removal of IL-1B or IL1R1 in syngeneic mouse models or pharmacological suppression of this cytokine/receptor in immune-compromised (T and B cell deficient) mouse strains led to the same effects, we hypothesised that IL-1B controls the growth of the primary tumour independently of the adaptive immune response. Here, IL1R1 is linked to neoplasm.